These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25261034)

  • 1. The low-dose atorvastatin and valsartan combination effectively protects the arterial wall from atherogenic diet-induced impairment in the guinea pig.
    Janić M; Lunder M; Zupan J; Černe D; Marc J; Drevenšek G; Šabovič M
    Eur J Pharmacol; 2014 Nov; 743():31-6. PubMed ID: 25261034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin, etidronate, or both in patients at high risk for atherosclerotic aortic plaques: a randomized, controlled trial.
    Kawahara T; Nishikawa M; Kawahara C; Inazu T; Sakai K; Suzuki G
    Circulation; 2013 Jun; 127(23):2327-35. PubMed ID: 23658438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silver fir (Abies alba) trunk extract protects guinea pig arteries from impaired functional responses and morphology due to an atherogenic diet.
    Drevenšek G; Lunder M; Benković ET; Mikelj A; Štrukelj B; Kreft S
    Phytomedicine; 2015 Aug; 22(9):856-61. PubMed ID: 26220633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with low-dose atorvastatin, losartan, and their combination increases expression of vasoactive-related genes in rat aortas.
    Lunder M; Drevenšek G; Černe D; Marc J; Janić M; Šabovič M
    J Cardiovasc Pharmacol Ther; 2013 Mar; 18(2):177-83. PubMed ID: 23091284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of raloxifene and atorvastatin in atherosclerotic process in ovariectomized rats.
    Cetinkaya Demir B; Uyar Y; Ozbilgin K; Köse C
    J Obstet Gynaecol Res; 2013 Jan; 39(1):229-36. PubMed ID: 22845341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of co-administration of atorvastatin and endothelin-1 receptor antagonist on the progression of atherosclerosis in rabbit.
    Sun Y; Liu J; Yang B; Sai X; Li T; Wang D; Zhou R
    APMIS; 2014 Jun; 122(6):556-64. PubMed ID: 24164644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques: a 2-year follow-up by noninvasive MRI.
    Yonemura A; Momiyama Y; Fayad ZA; Ayaori M; Ohmori R; Kihara T; Tanaka N; Nakaya K; Ogura M; Taniguchi H; Kusuhara M; Nagata M; Nakamura H; Tamai S; Ohsuzu F
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):222-8. PubMed ID: 19242355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis.
    Momi S; Monopoli A; Alberti PF; Falcinelli E; Corazzi T; Conti V; Miglietta D; Ongini E; Minuz P; Gresele P
    Cardiovasc Res; 2012 Jun; 94(3):428-38. PubMed ID: 22362817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Toll-Like Receptors 2, 3, 4, and 8 Is Correlated to the Vascular Atherosclerotic Process in the Hyperlipidemic Rabbit Model: The Effect of Statin Treatment.
    Kapelouzou A; Giaglis S; Peroulis M; Katsimpoulas M; Moustardas P; Aravanis CV; Kostakis A; Karayannakos PE; Cokkinos DV
    J Vasc Res; 2017; 54(3):156-169. PubMed ID: 28478461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of an add-on effect of probucol and cilostazol on the statin-induced anti-atherogenic effects.
    Wang Y; Bai L; Lin Y; Guan H; Zhu N; Chen Y; Li Y; Gao S; Zhao S; Fan J; Liu E
    Histol Histopathol; 2014 Dec; 29(12):1593-600. PubMed ID: 25078428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term atorvastatin improves age-related endothelial dysfunction by ameliorating oxidative stress and normalizing eNOS/iNOS imbalance in rat aorta.
    Gong X; Ma Y; Ruan Y; Fu G; Wu S
    Exp Gerontol; 2014 Apr; 52():9-17. PubMed ID: 24463049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eplerenone with valsartan effectively reduces atherosclerotic lesion by attenuation of oxidative stress and inflammation.
    Suzuki J; Iwai M; Mogi M; Oshita A; Yoshii T; Higaki J; Horiuchi M
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):917-21. PubMed ID: 16424347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-atherogenic effects of montelukast associated with reduced MCP-1 expression in a rabbit carotid balloon injury model.
    Ge S; Zhou G; Cheng S; Liu D; Xu J; Xu G; Liu X
    Atherosclerosis; 2009 Jul; 205(1):74-9. PubMed ID: 19110249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin restores the impaired vascular endothelium-dependent relaxations mediated by nitric oxide and endothelium-derived hyperpolarizing factors but not hypotension in sepsis.
    Subramani J; Kathirvel K; Leo MD; Kuntamallappanavar G; Uttam Singh T; Mishra SK
    J Cardiovasc Pharmacol; 2009 Dec; 54(6):526-34. PubMed ID: 19755915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice.
    Berbée JF; Wong MC; Wang Y; van der Hoorn JW; Khedoe PP; van Klinken JB; Mol IM; Hiemstra PS; Tsikas D; Romijn JA; Havekes LM; Princen HM; Rensen PC
    J Nutr Biochem; 2013 Aug; 24(8):1423-30. PubMed ID: 23337345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sub-therapeutic doses of fluvastatin and valsartan are more effective than therapeutic doses in providing beneficial cardiovascular pleiotropic effects in rats: A proof of concept study.
    Janić M; Lunder M; France Štiglic A; Jerin A; Skitek M; Černe D; Marc J; Drevenšek G; Šabovič M
    Vascul Pharmacol; 2017 Dec; 99():45-52. PubMed ID: 28951255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis.
    Winter PM; Caruthers SD; Zhang H; Williams TA; Wickline SA; Lanza GM
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):624-34. PubMed ID: 19356492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin restores arsenic-induced vascular dysfunction in rats: modulation of nitric oxide signaling and inflammatory mediators.
    Kesavan M; Sarath TS; Kannan K; Suresh S; Gupta P; Vijayakaran K; Sankar P; Kurade NP; Mishra SK; Sarkar SN
    Toxicol Appl Pharmacol; 2014 Oct; 280(1):107-16. PubMed ID: 25058445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The roles of nitric oxide and hydrogen sulfide in the anti-atherosclerotic effect of atorvastatin.
    Liu X; Ma D; Zheng S; Zha K; Feng J; Cai Y; Jiang F; Li J; Fan Z
    J Cardiovasc Med (Hagerstown); 2015 Jan; 16(1):22-8. PubMed ID: 24933195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effect of angiotensin-converting enzyme (ACE) and 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibition on inflammatory markers in atherosclerotic rabbits.
    Oubiña MP; de las Heras N; Cediel E; Sanz-Rosa D; Aragoncillo P; Díaz C; Hernández G; Lahera V; Cachofeiro V
    Clin Sci (Lond); 2003 Dec; 105(6):655-62. PubMed ID: 12848617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.